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Abstract
There continues to be a significant shortage of donor livers for transplantation. One impedi-
ment is the discard rate of fatty, or steatotic, livers because of their poor post-transplant
function. Steatotic livers are prone to significant ischemia-reperfusion injury (IRI) and data
regarding how best to improve the quality of steatotic livers is lacking. Herein, we use nor-
mothermic (37˚C) machine perfusion in combination with metabolic and lipidomic profiling to
elucidate deficiencies in metabolic pathways in steatotic livers, and to inform strategies for
improving their function. During perfusion, energy cofactors increased in steatotic livers to a
similar extent as non-steatotic livers, but there were significant deficits in anti-oxidant capac-
ity, efficient energy utilization, and lipid metabolism. Steatotic livers appeared to oxidize fatty
acids at a higher rate but favored ketone body production rather than energy regeneration
via the tricyclic acid cycle. As a result, lactate clearance was slower and transaminase levels
were higher in steatotic livers. Lipidomic profiling revealedω-3 polyunsaturated fatty acids
increased in non-steatotic livers to a greater extent than in steatotic livers. The novel use of
metabolic and lipidomic profiling during ex situ normothermic machine perfusion has the
potential to guide the resuscitation and rehabilitation of steatotic livers for transplantation.
Introduction
Liver transplantation remains the only cure for end-stage liver disease. However, there is a sig-
nificant shortage of donor livers resulting in waitlist mortality rates approaching 20% [1]. One
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major contributor to the shortage is the high discard rate of steatotic livers [2]. Transplantation
of livers with moderate (30–60%) and severe (>60%) macrosteatosis is associated with
increased rates of primary non-function, early allograft dysfunction (EAD), and decreased
graft survival [3, 4]. As a result, transplantation with such organs is not recommended.
Poor graft function following transplantation of steatotic livers is attributed to multiple
physical and metabolic abnormalities, culminating in decreased ability to tolerate ischemia-
reperfusion injury (IRI), which occurs during procurement, cold storage, and implantation. At
an anatomic level, the large lipid vesicles seen in macrosteatosis compress adjacent sinusoids
resulting in reduced sinusoidal perfusion compared to non-steatotic livers [5]. The reduced
sinusoidal flow at baseline becomes more pronounced following IRI and can both limit the
ability to recover from acute injury and promote further damage [6]. At the metabolic level,
steatosis is associated with decreased hepatocyte adenosine triphosphate (ATP) stores at base-
line, as well as impaired recovery of ATP stores after depletion [7–9]. Recovery from IRI is an
ATP-dependent process [10], indicating that steatotic livers again have decreased likelihood of
adequate function following transplantation. Moreover, steatotic hepatocytes have increased
sensitivity to oxidative stress due to a chronic reduction in anti-oxidant capacity and increased
reactive oxygen species [11], which can lead to graft necrosis following transplantation.
Normothermic machine perfusion (NMP) has already been demonstrated to decrease
organ discard rates and EAD, with equivalent graft survival compared to conventional static
cold storage (SCS) in spite of worse donor liver characteristics [12]. The ability to use steatotic
donor livers for transplantation without compromising patient outcomes would dramatically
increase the supply of available livers [13]. Machine perfusion provides an important platform
for pharmacologic intervention to rehabilitate these livers that would otherwise be discarded.
However, the deficiencies of steatotic livers during NMP at a cellular level are not well defined,
as fatty liver disease has many systemic contributors that are hard to separate from intrinsic
hepatocyte defects in vivo [14].
Ex situ NMP also offers the perfect platform to study liver metabolism in isolation. We
therefore performed the first reported metabolic and lipidomic profiling of steatotic and non-
steatotic human livers during ex situ NMP.
Methods
Donor livers
8 human donor livers (5 steatotic, 3 non-steatotic), declined for transplantation by all trans-
plant centers, with consent for research between August 2016 and April 2018 were included in
this study. All donor livers were received through New England Donor Services (NEDS); no
organs were procured from prisoners. Patients or their surrogates (including parents or legal
guardians) provided informed consent for use of donor organs in research; all consent was
obtained by donation coordinators employed by NEDS. No vulnerable populations were
involved in this study. The Massachusetts General Hospital Institutional Review Board (IRB)
and the NEDS approved this study (No. 2011P001496), and all studies were carried out in
accordance with IRB and NEDS approved guidelines. The main reasons for organ decline
were: 1) more than 30% macrosteatosis of the donor livers evaluated by histology at the time of
procurement, and 2) the combination of donation after circulatory death (DCD) and old
donor age or prolonged ischemia time (S1 Table).
Procurement and preparation of liver grafts
All donor livers were procured based on the standard technique of in situ cold flush using Uni-
versity of Wisconsin (UW) preservation solution. Procurement techniques for donation after
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brain death (DBD) or donation after circulatory death are previously described [15]. Warm
ischemic time (WIT) is defined as time from circulatory arrest to in situ cold flushing for DCD
livers. Cold ischemic time (CIT) is defined from in situ cold flushing to start of machine
perfusion.
Upon arrival to our perfusion lab, back table preparation of the livers was performed as
described previously [16].
Machine perfusion
Liver grafts were perfused for three hours using a pressure and temperature-controlled perfu-
sion device, Liver Assist (Organ Assist, Groningen, Netherlands), using a previously estab-
lished protocol [16]. During NMP, livers were perfused with a portal pressure of 7 mmHg and
mean hepatic arterial pressure of 70 mmHg. The temperature of the perfusate was maintained
between 36–38˚C. The perfusate consisted of Williams’ medium E supplemented with hydro-
cortisone, insulin, heparin [15], albumin, fresh frozen plasma and a hemoglobin-based oxygen
carrier, Hemopure1 (HbO2 Therapeutics LLC, Souderton, PA, USA). Detailed composition
is provided in the S1 Methods. The choice of oxygen carrier was based on a study demonstrat-
ing the efficacy of Hemopure compared to packed red blood cells during NMP of human liver
grafts [17, 18]. Perfusate samples were collected from the arterial inflow and venous outflow at
30-minute intervals. Blood gas and chemistry analysis was performed using i-STAT Blood
Analyzer (Abbott Point of Care Inc., Princeton, NJ, USA).
Evaluation of hepatic injury and function
Perfusion dynamics were recorded every 30 minutes. Vascular resistance was defined as perfu-
sion pressure divided by flow rate (mmHg1 min1 mL-1). Alanine aminotransferase (ALT) was
determined using Piccolo Xpress Chemistry Analyzer (Abbott Point of Care Inc., Princeton,
NJ, USA). The volume of bile produced was recorded at 1-hour intervals. Two wedge liver
biopsies were collected immediately prior to perfusion and then hourly during perfusion. One
tissue sample was snap-frozen in liquid nitrogen for future analysis or and the other preserved
in 10% formalin for histology. Perfusate nitric oxide levels were measured using a colorimetric
assay (Biovision, #K262).
Histological assessment
After formalin fixation, tissue samples were paraffin-embedded, and stained with hematoxy-
lin-eosin (H&E). Tissue slides were evaluated for macrosteatosis content and preservation
injury by a blinded expert pathologist [19]. Livers with�30% macrosteatosis on pre-perfusion
biopsy were allocated to the “steatotic” group.
Targeted metabolomics analysis–energy cofactors
Frozen liver biopsies from each time point (~25mg) were pulverized in liquid nitrogen and
analyzed for metabolic cofactors using a targeted multiple reaction monitoring analysis on a
Sciex TripleTOF 6600 Quadruple Time-Of-Flight system, performed at the principle research
institution. Metabolites were extracted using the protocol provided by Yuan et al. [20]. Con-
centrations of hepatic adenosine tri-, di-, and mono- phosphate (ATP, ADP, AMP), and
reduced and oxidized nicotinamide dinucleotide phosphate (NADPH, NADP+) were quanti-
fied. Energy charge was calculated as: [ATP + ADP�0.5] / [ATP+ADP+AMP].
Metabolic profiling of steatotic livers during normothermic machine perfusion
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Untargeted metabolomic and lipidomic analysis
Tissue biopsies of three livers from each group were analyzed for 1600 compounds of known
identity by Metabolon, Inc. (Durham, North Carolina). Metabolite analysis utilized a Waters
ACQUITY ultra-performance liquid chromatography (UPLC) and a Thermo Scientific
Q-Exactive high resolution/accurate mass spectrometer interfaced with a heated electrospray
ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass resolution.
Principal component analysis (S1 Fig), detailed methods, and statistical approach are provided
in the S1 Methods. The complete metabolomic and lipidomic profile for both groups is pro-
vided in the S1 Dataset.
Statistical analysis
Demographic and perfusion data are presented as the mean ± standard error of the mean (SEM),
unless otherwise specified, with statistical significance defined as P<0.05. Wilcoxon’s rank-sum
(Mann-Whitney U) test and Fischer’s exact test were used for continuous and categorical compar-
isons, respectively. Repeated measures data were analyzed using a random intercept mixed model
with a categorical effect of time. If between-group comparisons were made, the categorical effect
of group and the group by time interactions were added to the model. Statistical analysis was per-
formed using Stata 15.1 (StataCorp, College Station, Texas) and SPSS (IBM, Armonk, New York).
Graphics were created using Prism 8 (GraphPad, San Diego, California).
Results
Liver characteristics and hemodynamics
A comparison of donor characteristics among the steatotic (ST) and non-steatotic (NST) livers
is provided in Table 1. ST livers tended to have higher hepatic arterial and portal venous resis-
tance, but differences were not statistically significant (Fig 1).
Histological changes during perfusion
Liver biopsies collected before and after perfusion were evaluated for percent macrosteatosis.
Percent macrosteatosis did not change significantly in either group after 180 minutes of NMP
Table 1. Baseline donor characteristics and ischemic times of steatotic and non-steatotic livers.
Variables Non-steatotic Steatotic
(n = 3) (n = 5)
Age (years) 44 (28–60) 48.4 (37–55)





Type of donor liver
DCD 2 (66%) 2 (40%)
DBD 1 (34%) 3 (60%)
WIT (min) 34� 27�
CIT (min) 660 (360–930) 735 (463–935)




Estimates provided are the mean with range in parentheses.
� Indicates only one available data point for variable.
https://doi.org/10.1371/journal.pone.0228011.t001
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(Table 2). However, ST livers demonstrated severe sinusoidal congestion, disruption of the
central venous endothelial lining, and hepatocyte swelling compared to NST livers (Fig 2).
Liver function
ALT levels were higher in the ST compared to NST livers (Fig 3A), although the difference was
not statistically significant (4672 vs. 1757 U/L at 180 min, P = 0.18). Hourly bile production
was also similar in both groups (Fig 3B). Venous lactate levels were higher in the ST livers
throughout perfusion. Mixed model analysis demonstrated a significant difference in the rate
of change in venous lactate between the two groups from initiation of perfusion to 30 and 180
minutes (Fig 3C). Glucose concentrations in the perfusate increased in both groups and were
significantly higher in the ST livers after 90 minutes of perfusion (Fig 3D).
Fig 1. Vascular resistance during perfusion of steatotic and non-steatotic livers. Steatotic livers tend to have higher vascular resistance at initiation of perfusion,
which improves with time. No significant differences were observed between the groups with mixed model analysis. (a) Hepatic artery resistance and (b) Portal vein
resistance are shown during 3 hours of normothermic machine perfusion. Data shown as mean ± SEM. ST, steatotic; NST, non-steatotic.
https://doi.org/10.1371/journal.pone.0228011.g001
Table 2. Histologic macrosteatosis of perfused livers.
Macrosteatosis Percentage
Liver # Group Pre-Perfusion Post-Perfusion
1 Non-steatotic <5% <5%
2 Non-steatotic <5% <5%
3 Non-steatotic 15% 10%
1 Steatotic 30% 30%
2 Steatotic 60% 60%
3 Steatotic 30% 30%
4 Steatotic 30% 30%
5 Steatotic 80% 80%
Based on wedge liver biopsies taken prior to initiation of perfusion (pre-perfusion) and after 3 hours of perfusion
(post-perfusion)
https://doi.org/10.1371/journal.pone.0228011.t002
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Oxidative stress
Several antioxidant metabolites were closely examined. Glutathione is the major intracellular
redox agent and the ratios of its reduced and oxidized form indicate the degree of cellular oxi-
dative stress [21]. Reduced glutathione levels decreased hourly in ST livers (0.24–0.29 fold
change, P<0.05 for each hour, Fig 4A), and did so to a much lesser extent in NST livers (range
0.39–0.82, P not significant for each hour). Oxidized glutathione levels decreased in both
groups, with ST livers decreasing less from baseline compared to NST livers (Fig 4B).
N-acetylcysteine (N-Ac) is an effective free radical scavenger and an important precursor to
glutathione synthesis by providing the L-cysteine substrate [22]. N-Ac levels in NST livers
increased much more during perfusion (range 6.41–9.65 fold change, P<0.05 for each hour),
than in ST livers (range 1.94–2.27 fold, P<0.05 for each hour, Fig 4C).
Reactive oxygen species (ROS) suppress levels of nitric oxide (NO), a vasoprotective endo-
thelial signaling molecule, both by scavenging and by decreasing production [23]. NO perfus-
ate levels increased at each hour in NST livers and were significantly higher at 180 minutes
perfusion compared to ST livers (37.7 vs. 20.2 μM, P = 0.0253, Fig 4D).
Fig 2. Histologic differences between steatotic and non-steatotic livers before and after perfusion. Representative
H&E-stained liver sections from steatotic and non-steatotic livers shown pre-perfusion and post-perfusion (3 hours of
normothermic machine perfusion). Steatotic liver biopsies demonstrate large lipid macrodroplets in the cytoplasm of
hepatocytes. No significant change in macrosteatosis content was observed after three hours of perfusion in steatotic
and non-steatotic livers.
https://doi.org/10.1371/journal.pone.0228011.g002
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ATP production
ATP:ADP and ATP:AMP ratios were significantly higher at end-perfusion compared to pre-
perfusion in both groups (Fig 5A and 5B). Energy charge was not significantly increased until
180 minutes of perfusion in NST livers, whereas it was significantly increased by 60 minutes
perfusion in ST livers (Fig 5C). No significant changes were seen in NADPH:NADP+ ratios
except at 60 minutes in the NST livers (Fig 5D). Comparison of cofactor ratios between NST
and ST groups at each time point did not demonstrate any significant differences.
Fig 3. Characterization of liver function and injury during perfusion. (a) Release of alanine aminotransferase. ALT was higher in steatotic livers but did not reach
significance. (b) Bile production measured at each hour of perfusion. Bile production increased at comparable volumes between groups. (c) Lactate content measured in
the venous outflow of livers during perfusion. ST livers have higher lactate content and slower clearance compared to NST livers. (d) Glucose content measured in the
venous outflow. ST livers release higher levels of glucose during perfusion compared to NST livers. � indicates P<0.05 for random intercept mixed model comparison of
repeated measures data between groups. Comparisons are made at each time point between groups with respect to the measured change from time = 0 minutes. Data
shown as mean ± SEM. ST, steatotic; NST, non-steatotic.
https://doi.org/10.1371/journal.pone.0228011.g003
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Fatty acid oxidation. Carnitine is an essential cofactor in the transport of fatty acids into
mitochondria for oxidation. Carnitine levels decrease in both groups, though to a larger degree
in ST livers (ST range 0.53–0.57 fold change vs. NST range 0.78–0.83, P<0.10 for all). How-
ever, fatty acylcarnitine levels increased over time in NST livers and decreased in ST livers (Fig
6A and 6B).
Fatty acid oxidation (FAO) produces acetyl CoA, the necessary precursor for the tricyclic
acid cycle. Ketones bodies such as acetoacetate and β-hydroxybutyrate are synthesized from ace-
tyl CoA in the liver when glycogen stores are depleted as an alternative energy source for the
brain, heart, and muscle. Interestingly, β-hydroxybutyrate levels increased more in ST livers
(range 5.51–9.94 fold change, P<0.05) than NST livers (range 2.08–4.64 fold, P<0.05, Fig 6C).
Tricyclic acid cycle. The tricyclic acid cycle consumes acetyl CoA to generate reduced
nicotinamide adenine nucleotide (NADH), which is necessary to regenerate ATP in oxidative
phosphorylation. There is significant accumulation of α-ketoglutarate (range 2.98–3.14 fold,
Fig 4. Redox factor changes in steatotic and non-steatotic livers during perfusion. Ratio of metabolite concentration fold change at each hour of perfusion compared
to pre-perfusion concentration shown for (a) reduced glutathione, (b) oxidized glutathione, and (c) N-acetylcysteine. (d) Concentration of nitric oxide in perfusate
samples. Steatotic livers demonstrate significant deficits in redox capacity and NO synthesis during perfusion. �� indicates P�0.05, � indicates 0.05<P<0.10. ST,
steatotic; NST, non-steatotic; x-axis represents fold change at 60, 120, and 180 minutes compared to pre-perfusion concentrations for (a-c).
https://doi.org/10.1371/journal.pone.0228011.g004
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P<0.05) in ST livers, an upstream metabolite in the tricyclic acid (TCA) cycle. Conversely,
NST livers preferentially accumulate downstream metabolites, such as succinate, fumarate,
and malate (Fig 7A).
Glucose metabolism. Glycolysis is the breakdown of glucose to produce 2 molecules of
pyruvate for use in the TCA cycle. The pentose phosphate pathway runs in parallel to glycolysis
and generates NADPH and ribose-5-phosphate, a precursor to nucleotide synthesis. Tissue
levels of glycolytic intermediates glucose-6-phosphate (G6P), dihydroxyacetone phosphate
(DHAP), 2-phosphoglycerate (2-PG), and phosphoenolpyruvate (PEP) are lower during perfu-
sion in ST livers compared to NST livers (Fig 7B). Metabolites in the pentose phosphate path-
way similarly decreased more in ST livers compared to NST livers (Fig 7C).
Lipidomic profile
As expected, NST livers have different lipid composition compared to ST livers (S2 Table).
NST livers contain a much smaller proportion of triacylglycerol (TAG) content (37.1% pre-
Fig 5. Analysis of energy cofactor changes in steatotic and non-steatotic liver tissue during perfusion. (a) Measured ATP:ADP ratio, (b) ATP:AMP ratio, (c) energy
charge, and (d) NADPH:NADP+ ratios at each hour of perfusion. Energy charge was calculated as (2�ATP + ADP)/(ATP + ADP + AMP). Within group comparisons at
60, 120, and 180 minutes are made to a pre-perfusion measurement (time = 0 min). � indicates P<0.05 for random intercept mixed model comparison of repeat
measures data to pre-perfusion levels. Data shown are mean ± SEM. ST, steatotic; NST, non-steatotic.
https://doi.org/10.1371/journal.pone.0228011.g005
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perfusion and 34.9% after NMP), than ST livers (61.6% pre-perfusion and 62.9% after NMP).
The triacylglycerol:diacylglycerol (TAG:DAG) ratio decreased during perfusion in both
groups, but to a much larger degree in the NST group (NST -34% change vs. -10% change,
P = 0.0495).
The omega-3 (ω-3) polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA,
20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), as well as the intermediary docosapentae-
noic acid (DPA, 22:5n-3), decreased initially in their free fatty acid (FFA) form, returning to
baseline (fold change ratios approaching 1.0) at end-perfusion in NST livers but remaining
low in ST livers (Fig 8A–8C). As perfusion time increased, ST livers appeared to have higher
ω-3 PUFA levels in TAG form and lower levels in DAG form compared to NST livers. In cho-
lesterol ester form (CE), EPA, DHA, and DPA levels increased significantly in NST livers dur-
ing perfusion but did not change in ST livers (Fig 8D).
Arachidonic acid (AA, 20:4n-6), an omega-6 (ω-6) PUFA increased in both groups in FFA
form, though to a larger extent in NST livers. AA levels in DAG form increased in NST livers
during perfusion, but no similar pattern was observed in the ST livers. In TAG form, AA
increased slightly overall in both NST and ST livers (S2 Fig).
Fig 6. Metabolic capacity of fatty acid oxidation in steatotic and non-steatotic livers during perfusion. (a) Carnitine and (b) β-hydroxybutyrate concentration fold
change at each hour of perfusion compared to pre-perfusion concentration. (c) Heatmap of fatty acylcarnitine metabolite concentration fold change at each hour of
perfusion. Steatotic livers demonstrate upregulation of fatty acid oxidation, with resultant depletion of carnitine and fatty acylcarnitine levels during perfusion, but favor
greater ketone synthesis compared to non-steatotic livers. �� indicates P�0.05, � indicates 0.05<P<0.10. ST, steatotic; NST, non-steatotic; x-axis represents fold change
at 60, 120, and 180 minutes compared to pre-perfusion concentrations.
https://doi.org/10.1371/journal.pone.0228011.g006
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Bile acids
Cholesterol, taurine, and choline are substrates for bile acid synthesis in the liver. Tissue cho-
lesterol increased during the first 2 hours in NST livers, but decreased in ST livers (P<0.05 for
all, Fig 9A). Taurine levels decreased throughout perfusion in ST livers (P<0.05 for all), but
only at the end of perfusion in NST livers (Fig 9B). Choline levels increased significantly in
NST livers but not in ST livers (Fig 9C). Primary and secondary bile acids largely decreased in
ST livers compared to NST livers. Two exceptions to this pattern include glycoursodeoxycho-
late and tauroursodeoxycholate, which increased in ST livers during perfusion (Fig 9D).
Discussion
Resuscitating steatotic livers to expand the donor liver pool will be enhanced by knowledge of
the metabolic deficiencies specific to these organs. This data may also inform therapies
directed at treating hepatic steatosis in vivo. This study is the first of its kind to examine the
metabolic and lipidomic profiles of steatotic livers during oxygenated normothermic machine
perfusion. During NMP, steatotic livers suffer higher levels of oxidative stress, deficiencies in
Fig 7. Metabolic analysis of cellular metabolism in steatotic and non-steatotic livers during perfusion. Ratio of metabolite concentration fold change at each hour of
perfusion compared to pre-perfusion concentration shown for (a) tricyclic acid cycle, (b) glycolysis, and (c) pentose phosphate pathway. Steatotic livers demonstrate
decreased flux through each metabolic pathway. �� indicates P�0.05, � indicates 0.05<P<0.10. ST, steatotic; NST, non-steatotic; x-axis represents fold change at 60, 120,
and 180 minutes compared to pre-perfusion concentrations.
https://doi.org/10.1371/journal.pone.0228011.g007
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cellular metabolism, and altered lipid and bile acid metabolism compared to non-steatotic
livers.
Additionally, this work unveiled deficiencies in steatotic livers that may hinder optimal
function, while indicating potential solutions. For example, we found that ST livers generate
less NO than NST livers, which in the post-transplant setting would impair microcirculation
and increase endothelial damage. This could be the result of deformed sinusoids or uncoupling
of nitric oxide synthase leading to decreased NO availability as a result of increased ROS [5,
24, 25]. Indeed, chronic oxidative stress and inflammation from excessive FFA uptake and
FAO is a hallmark of NAFLD and progression to non-alcoholic steatohepatitis (NASH) [26].
Fig 8. ω-3 fatty acid lipidomic profiles of steatotic and non-steatotic livers during perfusion. Ratio of metabolite concentration fold change at each hour of perfusion
compared to pre-perfusion concentration shown for the free fatty acid (FFA) form of (a) eicosapentaenoic acid (EPA), (b) docosapentaenoic acid (DPA), and (c)
docosahexaenoic acid (DHA). (d) Heatmap of EPA, DPA, and DHA concentration fold changes in cholesterol ester (CE), FFA, monoacylglycerol (MAG), diacylglycerol
(DAG), and triacylglycerol (TAG) forms. �� indicates P�0.05, � indicates 0.05<P<0.10. ST, steatotic; NST, non-steatotic; x-axis represents fold change at 60, 120, and
180 minutes compared to pre-perfusion concentrations.
https://doi.org/10.1371/journal.pone.0228011.g008
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We confirmed that this is an intrinsic state of ST livers and not solely a reaction to the systemic
environment of metabolic syndrome by finding that ST livers during NMP still rapidly deplete
their supply of reduced glutathione and N-Ac. Perfusate supplementation with anti-oxidants,
such as Vitamin E, N-Ac, or L-alanyl-glutamine, could counteract the acute oxidative stress
and ROS that accompany IRI [27–30].
We also report the novel finding of fatty acylcarnitine metabolism during NMP, which
increased in concentration during perfusion of NST livers but decreased in ST livers. Trans-
port of fatty acylcarnitines into the mitochondria is an essential step in FAO. Carnitine supple-
mentation in human steatotic liver perfusion will likely decrease macrosteatosis by increasing
FAO, and has been shown to be effective in a rat fatty liver perfusion model [31, 32]. Interest-
ingly, in patients with NAFLD and NASH, absolute acylcarnitine levels actually increase with
disease progression, but this may be an attempt at mobilizing lipids for oxidation while still
Fig 9. Bile acid profiles of steatotic and non-steatotic livers during perfusion. Ratio of metabolite concentration fold change at each hour of perfusion compared to
pre-perfusion concentration shown for (a) cholesterol, (b) taurine, and (c) choline. (d) Heatmap of primary and secondary bile acid concentration fold changes during
perfusion. �� indicates P�0.05, � indicates 0.05<P<0.10. ST, steatotic; NST, non-steatotic; x-axis represents fold change at 60, 120, and 180 minutes compared to pre-
perfusion concentrations.
https://doi.org/10.1371/journal.pone.0228011.g009
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being insufficient for the degree of steatosis [33], as suggested by our ex situ NMP results.
Given the decreasing TAG:DAG ratio and increasing acylcarnitine concentrations, NST livers
appear to mobilize TAG stores much more efficiently for mitochondrial FAO. Conversely, ST
livers quickly deplete the available fatty acylcarnitine pool and are less capable of mobilizing
TAG stores for continued energy production.
Furthermore, NST livers favor efficient energy utilization pathways, as demonstrated by
comparatively lower ketone concentration increases and higher downstream TCA cycle
metabolite ratios. In comparison, ST livers demonstrate larger increases in ketone concentra-
tions ratios and higher α-ketoglutarate ratios, indicating the energy potential from FAO is
largely dissipated through excessive ketone body synthesis. This occurs in spite of higher per-
fusate glucose levels and insulin supplementation, which should decrease feedback to the liver
that the hypothetical brain and muscle bodies require ketones as an alternative energy source.
Elevated perfusate glucose concentrations in ST livers is also consistent with insulin-resistant
profiles seen in patients with non-alcoholic fatty liver disease (NAFLD) [14].
Interestingly, ST and NST livers regenerated similar ATP and energy charge ratios despite
abundant evidence of metabolic deficiencies. This is the first study to demonstrate that steato-
tic and non-steatotic livers are able to regenerate ATP and energy charge during NMP, which
is consistent with prior evidence from subnormothermic perfusion studies [15, 34]. The perfu-
sion data presented here support the idea that NMP partially resuscitates steatotic livers,
improving ATP and energy charge. Lee et al. demonstrated increased degradation of oxidative
phosphorylation subunits in a proteomic study of diet-induced NAFLD in mice [35]. The
resulting reduced efficiency of oxidative phosphorylation, the pathway downstream to the
TCA cycle, as a result of this supports the evidence in our study demonstrating a metabolic
barrier in the TCA cycle seen in ST livers. The equivalent ATP ratios between ST and NST liv-
ers therefore may indicate an invisible ceiling to energy production in ST livers rather than a
marker of adequate resuscitation. All perfused liver except one ST liver met the viability crite-
ria for transplant of Laing et al. [36], though ST livers required longer perfusion time to meet
criteria and met fewer total criteria compared to NST livers (S3 Table).
Another unique finding in this study is the pattern of ω-3 PUFA metabolism during perfu-
sion. DHA and EPA concentration ratios decrease in FFA form during perfusion in ST livers
and do not return to pre-perfusion levels, as they do in NST livers. Furthermore, DHA and
EPA were more favorably stored in TAGs in ST livers, whereas NST livers favored the mobi-
lized DAG, FFA, and CE forms. The downstream products of EPA and DHA include resolvins,
protectins, and maresins, generated via cyclooxygenase and lipoxygenase pathways [37]. These
metabolites possess anti-inflammatory and inflammation-resolving abilities, and have been
shown to inhibit tumor necrosis factor-α (TNFα) and interleukin-1β (IL-1β) production [38–
40]. DHA has also been demonstrated to activate peroxisome proliferator-activated receptor-γ
(PPAR-γ), which is an inhibitor of the proinflammatory nuclear receptor, NF-κB [37]. Prelim-
inary data from our lab indicates that ST livers express more inflammatory cytokines than
NST livers (manuscript in preparation); thus, perfusion supplementation with EPA and DHA,
currently unexplored, could improve ex situ resuscitation of steatotic livers by favoring anti-
inflammatory and inflammation-resolving pathways. In longer term in vivo studies in humans,
as well as in mice, ω-3 PUFA supplementation has been demonstrated to improve cardiovas-
cular risk, reduce steatosis, and decrease hepatic IRI [41–45].
This study is also the first to demonstrate how ST and NST livers modulate bile acid synthe-
sis during NMP. Given relative deficiencies in cholesterol, choline, and taurine concentrations
with increasing perfusion time, ST livers have similar overall deficits in primary and secondary
bile acid concentrations. Bile acid activation of the farnesoid X receptor (FXR) is a major sig-
naling pathway in hepatocytes. FXR activation has been demonstrated to increase FAO
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through PPAR-α activation, increase insulin sensitivity, and modulate triglyceride and lipo-
protein metabolism [46]. In a randomized prospective clinical trial, treatment of patients with
non-cirrhotic NASH using the semi-synthetic FXR agonist, obeticholic acid, demonstrated sig-
nificant improvement in fibrosis, steatosis, hepatocellular ballooning, and lobular inflamma-
tion compared to placebo [47]. By extension, perfusate supplementation with a natural or
synthetic FXR agonist could similarly optimize a steatotic liver’s cellular metabolism during ex
situ perfusion.
One limitation of this study was the relatively small group sizes. Research using discarded
human livers lends itself to significant heterogeneity between donors and randomization is not
feasible, so there is significant variance in not only demographic data, but also metabolic vari-
ability based on a donor’s medical history, procurement technique, and ischemic times. As a
result, this study was underpowered to compare perfusion dynamics between groups. How-
ever, corroborating prior studies, we did find that ST livers cleared lactate at a slower rate and
had higher hepatic arterial resistance during NMP [34, 48]. Notably, the primary endpoint of
this study was to compare the metabolic and lipidomic profiles of steatotic and non-steatotic
livers and not their perfusion characteristics, which have been extensively described in prior
studies [48, 49]. Furthermore, the use of multiple comparison corrections and false-discovery
rates, employed in the untargeted metabolic and lipidomic profiling, can compensate for the
small group sizes. This study also used Hemopure, a synthetic hemoglobin-based oxygen car-
rier, rather than traditionally used packed red blood cells (PRBC). We felt this provided a
more consistent representation of the metabolic changes occurring during perfusion, as PRBC
for research use are often obtained from multiple donors and could further confound the
metabolite data in the setting of erythrocyte hemolysis and immune-mediated phenomena
[18]. While we expect the use of a synthetic carrier helps minimize experimental variability,
some metabolic differences would be expected if a PRBC-based perfusate is used in future
studies, and comparisons with literature data should be done with caution accordingly. Simi-
larly, experience with use of Hemopure as the primary oxygen carrier during perfusion is
expanding and has several benefits, including a long shelf-life, low inflammatory profile, and
non-thrombogenicity [17, 18, 50]. Finally, we chose a three-hour perfusion as this is generally
the time frame in which transplant surgeons determine viability [36], as studies have noted
that a liver appears to reach a steady state in terms of perfusion parameters, functional bio-
markers, liver injury, and energy status by the end of three hours [15, 49]. Defining the meta-
bolic deficits during this time seemed to be most productive in identifying strategies to
optimize steatotic grafts for transplantation.
The lack of widely accepted criteria for determining when or if a machine-perfused liver is
adequately resuscitated for implantation is still a major impediment to broader clinical use of
discarded human livers after ex situ perfusion, though criteria have been proposed [36]. Real-
time lipidomic analysis using rapid evaporation ionization mass spectrometry (REIMS) has
been applied to endoscopic colonic polypectomy, as well as oncologic breast and ovarian sur-
gery [51–53]. Research on multiple–omics level data integration is also ongoing [54]. With the
development of these rapid analysis techniques, our novel combination of NMP with metabo-
lomic and lipidomic analysis could be integrated into the decision-making process of trans-
plant surgeons.
In conclusion, steatotic livers undergoing oxygenated normothermic machine perfusion
have significantly altered metabolic and lipidomic profiles compared to non-steatotic livers.
Improving the cellular metabolism of steatotic livers by targeting specific pathways with
metabolite supplementation and pharmaceuticals may allow significant resuscitation and reha-
bilitation of this subset of organs that would otherwise be discarded in the sequence of organ
procurement, thereby increasing the supply of organs for transplantation.
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Supporting information
S1 Dataset. Metabolomic dataset. Complete metabolomic and lipidomic dataset obtained
from untargeted mass spectrometry analysis provided in Excel spreadsheet format.
(XLSX)
S1 Fig. Multivariate analysis of metabolomic and lipidomic perfusion profiles. Principal compo-
nent analysis of ST (blue) and NST (red) livers based on tissue biopsies taken pre-perfusion (filled
circle), 60 min (open circle), 120 min (filled diamond), and 180 min (open diamond). (a) 3-dimen-
sional representation of untargeted metabolomic profile demonstrates group-wise clustering of ST
and NST during perfusion, whereas pre-perfusion profiles of the two groups are more similar. (b)
2-dimensial representation of untargeted lipidomic profile demonstrates group-wise clustering of
ST and NST livers at all time points. ST, steatotic; NST, non-steatotic; PC, principal component.
(EPS)
S2 Fig. Arachidonic acid lipid composition during perfusion. Heatmap of arachidonic acid
concentration fold changes in cholesterol ester (CE), free fatty acid (FFA), monoacylglycerol
(MAG), diacylglycerol (DAG), and triacylglycerol (TAG) forms. ST, steatotic; NST, non-stea-
totic; x-axis represents fold change at 60, 120, and 180 minutes compared to pre-perfusion
concentrations.
(EPS)
S1 Methods. Supplementary methods. Provides supplemental methods referenced in main
manuscript.
(DOCX)
S1 Table. Cause of death for donor livers. Listed cause of death for organ donors whose dis-
carded liver was included in this study.
(DOCX)
S2 Table. Lipid composition of perfused livers. Based on wedge liver biopsies taken prior to
initiation of perfusion (pre-perfusion) and after 180 minutes of perfusion (post-perfusion).
Cholesterol ester (CE), ceramide (CER), diacylglycerol (DAG), dihydroceramide (DCER), free
fatty acid (FFA), hexosylceramide (HCER), lactosylceramide (LCER), lysophosphatidylcholine
(LPC), lysophosphatidylethanolamine (LPE), phosphatidylcholine (PC), phosphatidylethanol-
amine (PE), phosphatidylinositol (PI), sphingomyelin (SM), triacylglycerol (TAG).
(DOCX)
S3 Table. Viability assessment of perfused livers. Based on viability criteria reported by
Laing et al. (reference 35). A perfused liver is deemed viable if it meets 2 or more criteria. NST,
non-steatotic liver; ST, steatotic liver; HA, hepatic artery; PV, portal vein.
(DOCX)
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